- Home
- VRDN vs LBTYB Comparison
VRDN vs LBTYB Comparison
Compare VRDN & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | LBTYB |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VRDN | LBTYB |
|---|---|---|
| Price | $30.11 | $15.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $41.42 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 133.9K |
| Earning Date | 02-26-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $70,789,000.00 | ★ $4,770,600,000.00 |
| Revenue This Year | $26,080.80 | $15.50 |
| Revenue Next Year | $2.07 | $1.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23340.07 | 170.50 |
| 52 Week Low | $9.90 | $9.15 |
| 52 Week High | $34.29 | $29.01 |
Technical Indicators
Market Signals| Indicator | VRDN | LBTYB |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 66.01 |
| Support Level | $28.92 | $14.01 |
| Resistance Level | $30.75 | $29.01 |
| Average True Range (ATR) | 1.47 | 1.60 |
| MACD | -0.40 | 0.60 |
| Stochastic Oscillator | 21.67 | 29.11 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.